Search: Biological chemistry, International
The 2007 Ig Nobel Chemistry prize winner was Mayu Yamamoto (International Medical Centre of Japan) for developing a way to extract vanillin (vanilla fragrance and flavour) from cow dung. The 2007 Ig Nobel Prize winners were announced 5th October 2007 and prizes prizes awarded at Harvard in America. To celebrate, a local ice cream bar put on a tasting session of a new flavour, Yum-A-Moto Vanilla Twist, concocted in honour of the 2007 Ig Nobel Chemistry Prize winner Mayu Yamamoto. The mind boggles.
The 2006 Ig Nobel Chemistry prize winner was Antonio Mulet, José Javier Benedito and José Bon of the University of Valencia, Spain, and Carmen Rosselló of the University of Illes Balears, in Palma de Mallorca, Spain, for their study "Ultrasonic Velocity in Cheddar Cheese as Affected by Temperature".
Anyone, anywhere with access to a personal computer, could help find a cure for cancer by giving 'screensaver time' from their computers to the world's largest ever computational project, which will screen 250 million molecules for cancer-fighting potential.
The project is being carried out by Oxford University's Centre for Computational Drug Discovery - a unique 'virtual centre' funded by the National Foundation for Cancer Research (NFCR), which is based in the Department of Chemistry and linked with international research groups via the world-wide web - in collaboration with United Devices, a US-based distributed computing technology company, and Intel, who are sponsoring the project.
Update: On Friday 27 April the Screensaver Project finally came to a close. The project, developed with the National Foundation for Cancer Research has run for six years and has at various times been funded by Intel, Microsoft and by IBM, but was chiefly a collaboration with United Devices Inc of Austin Texas.
It has been an enormous success, involving over 3.5 million personal computers in more than 200 countries. Only the SETI [Search for Extraterrestrial Intelligence] project has had more participants, but none has involved as much data transmission as this research.
The project built a database of billions of small drug-like molecules with known routes to synthesis. These compounds have been screened virtually to see if they might make potent inhibitors of proteins of known crystal structure and biological significance.